Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Leanne F. Harris"'
Publikováno v:
Molecules, Vol 25, Iss 4, p 833 (2020)
Haemostatic disorders are both complex and costly in relation to both their treatment and subsequent management. As leading causes of mortality worldwide, there is an ever-increasing drive to improve the diagnosis and prevention of haemostatic disord
Externí odkaz:
https://doaj.org/article/e5696877fcc94a988f27bf777344261a
Publikováno v:
Molecules
Articles
Molecules, Vol 25, Iss 4, p 833 (2020)
Articles
Molecules, Vol 25, Iss 4, p 833 (2020)
Haemostatic disorders are both complex and costly in relation to both their treatment and subsequent management. As leading causes of mortality worldwide, there is an ever-increasing drive to improve the diagnosis and prevention of haemostatic disord
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c43cd7eedf5f8cc59f90b617bdfb58dc
http://europepmc.org/articles/PMC7070452
http://europepmc.org/articles/PMC7070452
Publikováno v:
Journal of Shellfish Research. 34:585-694
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14c4938536273ef4544983eb5134aed1
https://doi.org/10.2983/035.034.0243
https://doi.org/10.2983/035.034.0243
The monitoring of bleeding and clotting risk is a critical component of patient care, as either excessive bleeding or abnormal clotting can have obvious and serious consequences for health and well-being and is related to many other co-morbidities. C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21cf91364193d39055a54c5aa6ac417f
https://doi.org/10.1016/b978-0-08-100072-4.00009-5
https://doi.org/10.1016/b978-0-08-100072-4.00009-5
Publikováno v:
Articles
Automated technologies have revolutionised the monitoring of coagulation disorders in the central hospital laboratory setting, allowing for high throughput testing, improved accuracy and precision, accompanied by a marked reduction in human error. Ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::183f8e77e3bd3939df20d2178ac3064a
https://doi.org/10.1016/j.trac.2013.05.009
https://doi.org/10.1016/j.trac.2013.05.009
Publikováno v:
Articles
Novel and sensitive plate-based fluorogenic anti-factor Xa (FXa) assays were investigated to quantify unfractionated heparin (UFH) in human plasma and whole blood within the therapeutic ranges of 0–1.6 U/mL and 0–0.8 U/mL, respectively. Two fluor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e8a0661c0fbf60a094b1a50e971e569
https://doi.org/10.1016/j.jpba.2011.07.025
https://doi.org/10.1016/j.jpba.2011.07.025
Publikováno v:
International Journal of Laboratory Hematology. 33:272-280
Summary Introduction: The most commonly used test for monitoring heparin therapy is the activated partial thromboplastin time (aPTT). The response of available aPTT reagents to heparin varies significantly. The aim of this study was to highlight the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83fe9a81038ddcd8e54498d17391b9a7
https://doi.org/10.1111/j.1751-553x.2010.01283.x
https://doi.org/10.1111/j.1751-553x.2010.01283.x
Publikováno v:
SPIE Proceedings.
Millions of patients worldwide are receiving anticoagulant therapy to treat hypercoagulable diseases. While standard testing is still performed in the central laboratory, point-of-care (POC) diagnostics are being developed due to the increasing numbe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b066dcaee7af1ec1801a8be47d55051
https://doi.org/10.1117/12.2016872
https://doi.org/10.1117/12.2016872
Publikováno v:
Articles
The development of new point of care coagulation assay devices is necessary due to the increasing number of patients requiring long-term anticoagulation in addition to the desire for appropriate, targeted anticoagulant therapy and a more rapid respon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5820a8deca7e005ffd066c92ec5ca09a
https://pubmed.ncbi.nlm.nih.gov/23666610
https://pubmed.ncbi.nlm.nih.gov/23666610
Publikováno v:
Articles
The most commonly used test for monitoring heparin therapy is the activated partial thromboplastin time (aPTT). The response of available aPTT reagents to heparin varies significantly. The aim of this study was to highlight the differences between aP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f1559e35fe79fb1b8f52cc986be53c9